|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Inhi- bition of platelet aggregation by AZD6140, a re- versible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes显示文摘 | Storey RF Husted S Harrington RA | 2007 | J Am Coll Cardiol2007，50，19： | 1 |
| 2 | Pharmaco kinetics and pharmacodynamics of ticagrelor in pa- tients with stable coronary artery disease: results from the ONSET OFFSET and RESPOND studies 显示文摘 | Husted SE Storey RF Bliden K | 2012 | Clin Pharmaeokinet2012，51，6： | 1 |
| 3 | Pharmacokinetics and pharmacodynamics of ticagrelor in patients with stable coronary artery disease: results from the ONSET - OFFSET and RESPOND studies 显示文摘 | Husted SE Storey RF Bliden K | 2012 | Clin Pharmacokinet2012，51，6： | 1 |
| 4 | Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes 显示文摘 | Storey RF Husted S Harrington RA | 2007 | J Am Coil Cardiol2007，50，19： | 1 |
| 5 | Changes in inflammatory biomarkers in patients treated with ti- cagrelor or clopidogrel 显示文摘 | Husted S Storey RF Harrington RA | 2010 | Clin Cardiol2010，33，4： | 1 |
| 6 | Pharmaeokineties and pharmacodynamics of ticagrelor in patients with stable coronary artery disease: results from the ONSET- OFFSET and RESPOND studies显示文摘 | HUSTED SE STOREY RF BLIDEN K et 01 | 2012 | Cliu Pharrnacokinet2012，51，6： | 1 |
| 7 | Pharmacokinetics and pharmacodynamics of ticagrelor in patients with stable coronary artery disease:results from the ONSET-OFFSET and RESPOND studies显示文摘 | Husted SE Storey RF Bliden K | 2012 | Clin Pharmacokinet2012，51，6： | 1 |
| 8 | Changes in inflammatory biomarkers in patients treated with tieagrelor or clopidogrel显示文摘 | Husted S Storey RF Harrington RA | 2010 | Clin Cardiol2010，33，4： | 1 |
| 9 | Vocorticoid-stimulsted lung epithelial Na (+) transport is associated with regulated ENaC and sgkl expression显示文摘 | Itani OA Auerbach SD Husted RF | 2002 | Am J Physiol lung Cell Mol Physiol2002，282，4： | 1 |
| 10 | Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes显示文摘 | Storey RF Husted S Harrington RA | 2007 | J Am Con Cardio12007，50，19： | 1 |
| 11 | Inhi- Bition of platelet aggregation by AZD6140, a revers- ible oral P2Y12 receptor antagonist, compared with elopidogrel in patients with acute coronary syn- dromes显示文摘 | Storey RF Husted S Harrington RA | 2007 | J Am Coll Cardiol2007，50，19： | 1 |
| 12 | Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes显示文摘 | Storey RF Husted S Harrington RA | 2007 | J Am Coil Cardiol2007，50，19： | 1 |
| 13 | Inhibition of platelet aggregation by AZD6140,a reversible oral P2Y12 receptor antagonist,compared with clopi- dogrel in patients with acute coronary syndromes显示文摘 | Storey RF Husted S Harrington RA | 2007 | J Am Coll Cardiol2007，50，19： | 1 |
| 14 | Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrelin patients with acute coronary syndromes 显示文摘 | Storey RF Husted S Harrington RA | 2007 | J Am Coil Cardiol2007，50，9： | 1 |
| 15 | Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes显示文摘 | STOREY RF HUSTED S HARRINGTON RA | 2007 | J Am Coll Cardiol2007，50，19： | 1 |
| 16 | Glucocorticoid-stimulated lung epithelial Na + transport is associated with regulated ENaC and sgkl expression 显示文摘 | Itani OA Auerbach SD Husted RF | 2002 | Am J Physiol Lung Cell Mol Physiol2002，282，4： | 1 |
| 17 | Pharmacokinetics and pharmacodynamics of ticagrelor in patients with stable coronary artery disease: results from the ONSET-OFFSET and RESPOND studies显示文摘 | Husted SE Storey RF Bliden K | 2012 | Clin Pharmacokinet2012，51，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员